Spirit (SAVE) a distressed merger partner with Jet Blue LONGSAVE on the 50-minute chart reversed a trend down that started on January 23 which was a
continuation of a previous downtrend which corrected. SAVE is in critical condition. There is a
merger with JBLU which has been successfully challenged in court. The two airlines have a
narrow window in which to file a notice of appeal after which briefing and oral argument
will be calendared. This is a slow process. I cannot find a positive piece of news in this
current week. No matter, price crossed over both short and longer moving averages and had
little bit of more volume. Is this a fakeout? Is this a short squeeze without volume to keep
it going? Are shorts buying to cover? Could this turn into something or is it nothing ?
Who knows ! I think it is worth watching.
Mergers
$CMGR Past hit $28 now .0035 7 Mil Float Tons of News and PRsImmense interest is still on this gem after moving 500%+ twice within the last month. It seems dilution has slowed down tremendously and it has found a bottom finally down here in the high .0030s to .0040s
I would anticipate another move is percolating and hopefully is sustained on a longer time scale, as it did in the past when it moved from .05 to $28 granted the float was probably closer to 1,000,000 back them, it being 7x that now we wont be seeing such an immense move but a $1+ move isn't out of the question given how easily it moves on news.
Its most recent 8K stated that GS Capital agreed to convert a convertible promissory, dated November 26, 2021, in the aggregate principal amount of $300,445 (the “Converted Note”), at the conversion price of $1.00
Which states there may very well be much more to come and to anticipate a much larger move on the horizon.
The company closed a promo deal with “The Farmers Dog, inc” raising a total funding of $103.1 Million
The company now has promo deals with Target, Dutch Bros. Coffee and Rob Gronkowski
In addition to several other recent deals inked.
ATVI Merger Arbitrage - Risks and ReturnsAs a followup to my post earlier today I wanted to give some additional perspective on past Merger Arbitrages, both good and bad, using the Baxter NYSE:BAX buyout of Hill-Rom last year and the failed buyout of Rite-Aid NYSE:RAD by Walgreens NASDAQ:WBA in 2015.
$APOP and Quoin Pharmaceuticals Announce Strategic MergerCellect Biotechnology and Quoin Pharmaceuticals Announce Strategic Merger
Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger
Cellect shareholders to retain 25% of the combined Company pre-funding
Quoin has secured $25 million in committed equity funding from Altium Capital, a highly regarded institutional healthcare investor.
Quoin has also negotiated an $18.5 million venture loan from a leading U.S. commercial bank.
Completion of the merger is subject to approval of the Cellect and Quoin shareholders and certain other conditions and is expected to close by the end of the second quarter of 2021.
$ANCN Announces Shareholder Approval of the Merger with ChemomabAnchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
Anchiano shareholders approve all resolutions at shareholder meeting
The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.
finance.yahoo.com
$JCS Announces Agreement to Merge with Pineapple Energy, LLCCommunications Systems, Inc. Announces Agreement to Merge with Pineapple Energy, LLC
$JCS ("CSI" or the "Company"), an IoT intelligent edge products and services company, today announced that it entered into a definitive merger agreement with privately held Pineapple Energy, LLC ("Pineapple"), a growing U.S. operator and consolidator of residential solar, battery storage, and grid services solutions.
Pineapple recently signed definitive agreements to acquire Hawaii Energy Connection ("HEC") and E-GEAR, both Hawaii-based sustainable energy solution providers.
This transaction will pave the way for the combined company to effectively raise capital and use stock as a currency to acquire other leading regional solar, storage and energy services companies."
CSI expects the sale proceeds from any pre-merger divestitures to be distributed in the form of a cash dividend to existing CSI shareholders prior to the effective date of the merger. In addition to any proceeds from pre-merger divestitures, CSI expects to distribute to the pre-merger shareholders a cash dividend of at least $1.00 per share prior to the closing of the merger. The Company also intends to make additional cash dividends from cash, cash equivalents, and investments and proceeds from the sale of legacy CSI assets and businesses sold after the merger through the CVRs.
Each CSI shareholder as of the merger record date, will receive Contingent Value Rights ("CVRs") that reflect the right to receive that shareholder’s percentage of the net proceeds from the sale of legacy CSI businesses and assets, after the closing.
Additionally, current CSI shareholders will retain shares in the combined company, initially holding approximately 37% of total shares outstanding. This ownership is expected to decrease over time due to earnouts to Pineapple shareholders and capital to be raised through potential future equity offerings.
Other information about the Merger and Related Transaction
The transaction is structured as a statutory reverse triangular merger under Delaware law under which a new CSI subsidiary will be merged with and into Pineapple. Pineapple will survive the merge r and become a wholly-owned subsidiary of CSI.
The Members of Pineapple will receive base consideration of 15.6 million shares of CSI common stock. The base consideration will be increased for any outstanding convertible notes issued by Pineapple in a pre-closing financing, which will convert into additional shares of CSI common stock at a rate of $2.00 per share and be decreased for any outstanding indebtedness of Pineapple in excess of $22.5 million, which will reduce the base consideration at a rate of $2.00 per share;
In addition to the base consideration, Members of Pineapple may receive additional shares pursuant to an earnout. Additional shares of common stock will be issued to Members of Pineapple upon the occurrence of the specific milestones.
Financing Growth
In conjunction with the merger, CSI and Pineapple Energy are exploring equity financing through a private placement that would close in connection with the closing of merger, with proceeds to be used by the combined company to finance additional acquisitions and working capital needs of the combined company.
$WIFI to be Acquired by Digital ColonyBoingo Wireless to be Acquired by Digital Colony
Boingo Shareholders to Receive $14.00 per share in Cash Transaction Valued at Approximately $854 Million.
Leading Digital Infrastructure Investment Firm, Digital Colony, Uniquely Positioned to Continue Investing in Boingo’s Diverse Network.
Boingo to Become a Privately Held Company Upon Completion of Transaction.
Digital Colony will acquire all the outstanding shares of Boingo common stock for $14.00 per share in cash through a merger, in a transaction valued at approximately $854 million, including the assumption of $199 million of Boingo’s net debt obligations. The acquisition price represents a 23% premium to Boingo’s closing price of $11.40 on February 26, 2021.
expected to close in the second quarter of 2021.
finance.yahoo.com
Rocket Lab to Become Publicly Traded Through Merger with $VACQRocket Lab, an End-to-End Space Company and Global Leader in Launch, to Become Publicly Traded Through Merger with Vector Acquisition Corporation.
End-to-end space company with an established track record, uniquely positioned to extend its lead across a launch, space systems and space applications market forecast to grow to $1.4 trillion by 2030
One of only two U.S. commercial companies delivering regular access to orbit: 97 satellites deployed for governments and private companies across 16 missions.
Transaction will provide capital to fund development of reusable Neutron launch vehicle with an 8-ton payload lift capacity tailored for mega constellations, deep space missions and human spaceflight
Proceeds also expected to fund organic and inorganic growth in the space systems market and support expansion into space applications enabling Rocket Lab to deliver data and services from space
Business combination values Rocket Lab at an implied pro forma enterprise value of $4.1 billion. Pro forma cash balance of the combined company of approximately $750 million at close
Rocket Lab forecasts that it will generate positive adjusted EBITDA in 2023, positive cash flows in 2024 and more than $1 billion in revenue in 2026
Group of top-tier institutional investors have committed to participate in the transaction through a significantly oversubscribed PIPE of approximately $470 million, with 39 total investors including Vector Capital, BlackRock and Neuberger Berman.
finance.yahoo.com
Viracta Therapeutics Announces Closing of Merger with $SNSSViracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement
Shares of Viracta to commence trading on the Nasdaq Global Select Market on February 25, 2021 under ticker symbol 'VIRX'
Cash and cash equivalents of over $120 million as of merger close
Registration trial for the treatment of relapsed/refractory EBV-positive lymphoma expected to begin in 1H2021, and a Phase 1b/2 trial in EBV-positive solid tumors in 2021.
The combined, publicly traded company will focus on the advancement and expansion of Viracta's clinical stage pipeline, including Viracta's lead program for the treatment of Epstein-Barr virus (EBV)-positive lymphoma.
Immediately prior to the closing of the merger, Viracta also closed the previously announced $65 million private placement of its common stock.
On February 24, 2021, and in connection with the closing of the merger, Sunesis effected a 1-for-3.5 reverse stock split . All issued and outstanding shares of common stock of Sunesis were subject to the reverse stock split.
Viracta has approximately 37.0 million shares of common stock outstanding , with pre-merger Viracta shareholders collectively owning approximately 86.05% of the combined company and pre-merger Sunesis shareholders collectively owning approximately 13.95% of the combined company.
finance.yahoo.com
Berkshire Grey Announces Business Combination with $RAAC spacBerkshire Grey, a Leader in AI-Enabled Robotics and Automation Solutions, Announces Business Combination with Revolution Acceleration Acquisition Corp
Combined company to have an estimated post-transaction equity value of up to $2.7 billion
Transaction expected to provide up to $413 million in cash proceeds, including a fully committed PIPE of $165 million anchored by Chamath Palihapitiya, Founder and CEO of Social Capital, Hedosophia and funds and accounts managed by BlackRock
Current Berkshire Grey shareholders Khosla Ventures, New Enterprise Associates, Canaan Partners and SoftBank Group Corp. rolling 100% of their equity in the combined company
Berkshire Grey expects to have $507 million cash, which will be used to fund operations and support new and existing growth initiatives, and no debt on its balance sheet following the combination.
The intellectual property supporting BG’s market-leading solutions is protected by more than 300 patent filings.
The intellectual property supporting BG’s market-leading solutions is protected by more than 300 patent filings.
Transaction is expected to close during the second quarter of 2021 and is subject to approval by RAAC’s stockholders and other customary closing conditions.
finance.yahoo.com
$SNSS Definitive Merger Agreement CASE STUDYSunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
Merger to create Nasdaq-listed company focused on developing Viracta’s precision oncology pipeline targeting virus-associated malignancies
Leading institutional investors committed a total of $105 million in private financings with Viracta
Combined company expected to have approximately $120 million cash balance following the close of the merger
intends to be listed on the Nasdaq Global Market under the ticker symbol “VIRX.”
Viracta plans to initiate a registration trial for the treatment of EBV-positive lymphoma in the first half of 2021, and also plans to initiate a Phase 1b/2 trial in EBV-positive solid tumors in 2021.
The transaction is expected to close in the first quarter of 2021.
finance.yahoo.com
NEWEGG.COM merger hypeThere does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media-Twitter and Twitter hashtags.
TWITTER:
$LLIT $15-17 then $20+ into NEWEGG.COM merger on bitcoin
$LLIT swing is alive. Proxies have been filed. http://NEWEGG.com!!! Easy $20 into merger, if not more, IMO.
$LLIT Merger Docs out today on NewEgg 1B+ Merger. Very low float, be smart. $20-30
$LLIT will become a bitcoin play as they merge with newegg.
$LLIT Great dip. After the proxy filing this should really start heating up next week. $20+ low end price target for the merger.
18% of the float is short. This could squeeze
Q1 merger playHyping on twitter:
Traders Citing Monday Filing Mentioning Proposed Merger of Co With StemoniX
Q1 merger play 6.5m float.
Three different 13G's filed in the last few days two 10% and one 5%
www.marketscreener.com
Atlantic Power Agrees to be Acquired by I Squared CapitalAtlantic Power Agrees to be Acquired by I Squared Capital
Common shareholders to receive US$3.03 per share in cash, representing a 48% premium to the 30-day volume weighted average price per common share on the NYSE
- Convertible debentures to be converted to common shares, including a make whole premium; following conversion, debenture holders will receive US$3.03 per share in cash
- Preferred shareholders and medium term noteholders to receive cash representing meaningful premiums to recent trading prices.
The total enterprise value of the deal is approximately US$961 million (based on current foreign exchange rates) and the transaction was unanimously approved by Atlantic Power's board of directors.
Atlantic Power's 6.00% Series E Convertible Unsecured Subordinated Debentures due January 31, 2025 will be converted into common shares of Atlantic Power immediately prior to the closing of the transaction based on the conversion ratio in effect at such time (including the "make whole premium shares" issuable under the terms of the trust indenture for the convertible debentures following a cash change of control).
Holders of the convertible debentures will receive US$3.03 per common share held following the conversion of the convertible debentures, plus accrued and unpaid interest on the convertible debentures up to, but excluding, the closing date of the transaction.
finance.yahoo.com
INAQ update - plot buys across the wicks on the trendlineBullish on INAQ and scaling in gradually to this SPAC under $14.
I like SPACs between $10 - 13 as there is very little downside but a lot of potential upside just before the ticker changes.
Looking at this chart my plan is to keep scaling in according to this wicks on the diagonal trendline which are like clockwork.
So next buy would be around 12.90 tomorrow - let's see if it pans out. I'm going to trade off this chart until the pattern changes, most likely that'll occur the closer we get to 13.5 which is the most significant local resistance.
Once INAQ breaks 13.5 I expect this to soar and be at $16 quite quickly. This can all be invalidated by a sell-off near that level or at the resistance. In that case, I will re-evaluate and look at support levels.
But classing this one as an 'investment' not a trade (until ticker changes over). Of course, do your own research and always know what type of trade you're taking before you enter in.
SNDL MERGER - This stock was $2 before the crash..... wait to buy in and volume kicks in. Don't pre market.. It will retest lower first to confirm support!
Merger Arb?These are all acquisition targets that had been trading at their tender offer price for at least a month before the reaction. My guess is that they were indiscriminately sold off by institutions without paying much attention to the state of the deal.
Under the assumption that these firms will still be acquired, there should be alpha in these positions because they should not be traded based on market risk but instead on the likelihood they will be acquired
OPGN. P-Modeling Pt X. The Cajun's of Hyperspace TravelWelcome Hyperspace Traveler!
This is Trial X on OPGN.
Trial X is special.
Come join me...
This would be a great place to reverse. ^evil smile^.
Let's see how this goes!
Start//: Before Snapshot.
End//: After Snapshot.
45 minute TF>
Massive Harmonic Suppression..
Amplification imminent.
This model adheres to Time-Series
Failure is a necessary component of success.
Entry Avg $2.70- $3.48 @12,100 shares.
Target: $38.00 -$41.00
Knife Catch: ??
When:> Before April 20th.
Approx Profit if Quantum Model is followed: $459,800 - $496,000
Why?
Catalyst: Corvid-19 test kits, Merger, FDA approval, Diagnostics.
Come for the laughs,
Stay for the Art.
____________________________
If you are lurking, let me know.
Thanks for Pondering the Unknown with Me,
Glitch420
Short On $S Just Hit New Milestone: Penny StockWell... it finally happened. Sprint NYSE:S TMUS is now on everyone's list of penny stocks after this week. Shares dropped below $5 on Thursday and firmly closed near its low of the day on Friday. Next week will be interesting to see closing arguments to the opposition so this could either be a blowout or a blow-up.
"On Friday, a Washington, D.C. federal court set January 24 as the deadline for briefs in its Tunney Act proceeding. According to its definition, the Tunney Act, 'requires federal courts to review each consent decree in civil antitrust cases filed by the DOJ to ensure that the remedy proposed in the consent is in the public interest.'
Two US agencies already rubber-stamped the deal but the multiple state attorneys general in several states have gone against the grain. Closing arguments in these lawsuits are scheduled for Wednesday. If the states win, the Tunney review is basically a wash. However, if the companies come up with a “W,” there could be a chance the two respective executive teams will work towards swift close to the transaction."
SOURCE: pennystocks.com
Sell Broadcom on this Symantec Acquisition, $20B Down The TubesBloomberg broke the news on Wednesday July 3rd, 2019 that Broadcom is in talks to buy struggling Symantec. This is a terrible idea on many fronts and $AVGO closed down 3% on the news. I believe that investors do not want this semiconductor company to waste $20 billion on a cybersecurity company (and why pick the one that seems to be struggling the most?). Certainly makes sense that we head lower over the next few days/weeks.
A few references:
AbbVie buying Allergan - stock closed down 15%
Salesforce buying Tableau - stock closed down 3% (but it hasn't dropped further)
Goldman Sachs and B&B hotels mergeGoldman Sachs, one of the largest investment banks in the market, this Monday announced the ongoing negotiations for the purchase of B & B Hotels from a private investment company PAI Partners. According to the previous Financial Times report, the hotel chain is estimated at 1.9 billion euros, which is equivalent to 2.1 billion dollars.
$SODE Makes Headlines: Acquisitions and 50M Share Retirement$SODE just recently announced they acquired BitPlaza Inc., the worlds first bitcoin shopping center in the App Store. This is major news for SODE. This strategically couples to company to bitcoin and other blockchain related news. This is great as BTC recently has made a bullish run. Most analyst and investors believe this bullish run is going to continue its trend. As SODE 52 week highs have been upwards of .335 per share, off recent news, there is growing belief this company could be heavily undervalued.
$HIPH CEO Confirms Order Delivery to Start Next Week: CBD WaterThe CEO of $HIPH A Expansive High Growth MJ Stock with several acquisitions in the pipe and more to come, has announced that the deliveries for the CBD+Hydro Infused High PH Water will start delivery next week and explained the situation in a tweet earlier today:
"Wanted to provide an update, orders will be shipping out next week! Again apologies for delays, migrations issues, etc caused the initial delays, much smoother going forward, 3 weeks for delivery not acceptable. Thanks for everyone's patience! $HIPH"
The technicals of the chart also show triangular formations on the hourly going back a month in an upwards direction which confirms the uptrend.
Below are some of the major catalysts coming up for the MJ Sector as a whole:
Pending US Federal Hemp/CBD legalization DD/research links:
(1.)
The current Farm Act expires Sept 30th, 2018, legislators will attempt to pass a new Farm Act before the current Act expires, meaning; there's aprox. 99%+ certainty that the proposed US Federal Hemp/CBD legislation will be dealt with by congress in one way or the other on or before Sept 30th, 2018.
www.washingtonpost.com
The Hemp Farming Act of 2018 contains full spectrum legalization of Hemp & CBD on a US Federal level
en.wikipedia.org
It is easy to under-estimate the potential economic impact of US Federal Hemp/CBD legalization, but consider;
Hemp/CBD has been federally restricted for over 80 years.
en.wikipedia.org
Not only does CBD derived from Hemp have potential mass use on a national/federal level, but the Hemp by-products of CBD production have approximately 10,000 different additional uses:
www.bulkhempwarehouse.com
The US Federal legalization of Hemp/CBD is essentially a once-in-a-century event.
(2.)
On Oct. 17th Canada will experience full Marijuana legalization. This will also be another catalysts and full spectrum legalization of MJ in Canada puts pressure on the US to pass full spectrum legalization of Hemp/CBD for US Farmers to stand a chance of being able to compete with the Canadians in the massive international Hemp/CBD space.
(3.)
With 2018 being a mid-term election year; Cannabis stocks tend to out-perform when legalization is on the ballot, see the following 2 videos for further explanation:
pro.moneymappress.com
secure.caseyresearch.com
This November 6th these 4 states will vote to legalize Marijuana in different forms:
North Dakota: Recreational Marijuana.
Michigan: Recreational Marijuana.
Utah: Medical Marijuana.
Missouri: Medical Marijuana.
